Cc9f267dcClaimEli Lilly reported non-GAAP earnings per share of $7.48, beating analyst expectations of $6.26 by $1.22AgreeDisagree
Cc9f267dcClaimEli Lilly increased its full-year 2024 revenue guidance from $85 billion to $87 billion up to a revised range of $91 billion to $92 billionAgreeDisagree
Cc9f267dcClaimEli Lilly's weight-loss drug Zepbound generated $5 billion in quarterly revenue, marking a 50% year-over-year increaseAgreeDisagree
Cc9f267dcClaimEli Lilly reported a gross profit margin of 83% for the third quarter of 2024AgreeDisagree
Cc9f267dcClaimOracle announced at its late 2024 investor day that the company does not expect to require substantial external capital raises through 2030AgreeDisagree
Cc9f267dcClaimRobinhood reported quarterly cryptocurrency revenue of $120 million, representing a 20% quarter-over-quarter increaseAgreeDisagree
Cc9f267dcClaimRobinhood Chain generated approximately $50 million in revenue during its first reported operating quarterAgreeDisagree
Cc9f267dcClaimDespite Nvidia reporting earnings and guidance far exceeding estimates, its stock remained unchanged, leading to a P/E multiple compressionAgreeDisagree
Cc9f267dcClaimMicron's new long-term agreements are expected to reduce the cyclicality of its earningsAgreeDisagree
Cc9f267dcClaimMicron's earnings came in better than expected, and the company signed new long-term agreementsAgreeDisagree
Cc9f267dcClaimFor the past 12 months, public companies have consistently discussed their use of AI on earnings callsAgreeDisagree
Cc9f267dcClaimMeta raised the lower end of its capital expenditure (CapEx) guidance by $5 billionAgreeDisagree
Cc9f267dcClaimMeta's stock fell 10% following its earnings call where it raised CapEx guidanceAgreeDisagree
Cc9f267dcClaimCorporate earnings per share (EPS) and future EPS projections are growing at a high rateAgreeDisagree